Free Trial

Vertex Pharmaceuticals (VRTX) Insider Trading & Ownership

Vertex Pharmaceuticals logo
$450.97 +0.60 (+0.13%)
(As of 11/22/2024 ET)

Vertex Pharmaceuticals (NASDAQ:VRTX) Insider Buying and Selling Activity

Current
Insider Ownership
Percentage
0.20%
Number Of
Insiders Buying
(Last 12 Months)
0
Number Of
Insiders Selling
(Last 12 Months)
12
Amount Of
Insider Selling
(Last 12 Months)
$36.82 M
Get VRTX Insider Trade Alerts

Want to know when executives and insiders are buying or selling Vertex Pharmaceuticals stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

VRTX Insider Buying and Selling by Quarter

Vertex Pharmaceuticals Insider and Congressional Trades History

Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
11/15/2024David AltshulerEVPSell15$478.56$7,178.40  
8/30/2024Jeffrey M LeidenChairmanSell3,784$499.00$1,888,216.00  
8/30/2024Sangeeta N BhatiaDirectorSell646$500.00$323,000.00  
8/7/2024Carmen BozicCMOSell2,280$476.75$1,086,990.00  
8/1/2024Bruce I SachsDirectorSell5,295$508.00$2,689,860.00  
7/24/2024Carmen BozicCMOSell2,280$488.46$1,113,688.80  
7/22/2024Reshma KewalramaniCEOSell15,202$497.00$7,555,394.00  
7/10/2024Carmen BozicCMOSell2,280$487.34$1,111,135.20  
6/26/2024Carmen BozicCMOSell2,280$471.72$1,075,521.60  
6/12/2024Carmen BozicCMOSell2,280$478.00$1,089,840.00  
6/12/2024Edward Morrow Atkinson IIIEVPSell7,288$478.00$3,483,664.00  
5/30/2024Ourania TatsisEVPSell2,350$439.11$1,031,908.50  
5/29/2024Carmen BozicCMOSell2,280$445.56$1,015,876.80  
5/28/2024Charles F Wagner JrCFOSell3,250$454.79$1,478,067.50  
5/24/2024Reshma KewalramaniCEOSell1,565$457.00$715,205.00  
5/22/2024Bruce I SachsDirectorSell7,073$448.00$3,168,704.00  
5/3/2024Tommy TubervilleU.S. Congress Member (R-AL)Sell$401.08$1,001 - $15,000
2/26/2024Ourania TatsisEVPSell354$425.70$150,697.80  
2/20/2024Ourania TatsisEVPSell480$420.79$201,979.20  
2/12/2024Amit SachdevEVPSell3,222$420.24$1,354,013.28  
2/12/2024Jeffrey M LeidenChairmanSell2,656$419.51$1,114,218.56  
2/12/2024Kristen AmbroseCAOSell1,374$420.24$577,409.76  
2/12/2024Stuart A ArbuckleCOOSell4,295$420.24$1,804,930.80  
1/8/2024Jeffrey M LeidenChairmanSell6,648$419.07$2,785,977.36  
(Data available from 1/1/2013 forward)

VRTX Insider Trading Activity - Frequently Asked Questions

0.20% of Vertex Pharmaceuticals stock is owned by insiders. Learn more on VRTX's insider holdings.

The following insiders have sold VRTX shares in the last 24 months: Amit Sachdev ($1,354,013.28), Bastiano Sanna ($5,176,395.04), Bruce I Sachs ($21,162,600.50), Carmen Bozic ($14,548,270.35), Charles F Wagner Jr ($3,998,815.80), David Altshuler ($427,969.53), Edward Morrow Atkinson III ($3,483,664.00), Jeffrey M Leiden ($13,592,878.66), Jonathan Biller ($211,523.60), Kristen Ambrose ($1,019,800.59), Lloyd Carney ($865,404.00), Ourania Tatsis ($2,456,075.67), Reshma Kewalramani ($15,324,767.36), Sangeeta N Bhatia ($786,860.82), Stuart A Arbuckle ($8,449,055.39), and Yuchun Lee ($2,518,290.59).

Insiders have sold a total of 252,009 Vertex Pharmaceuticals shares in the last 24 months for a total of $95,376,385.18 sold.

Tommy Tuberville (R-AL) has sold shares of Vertex Pharmaceuticals in the last year totaling $8,000.

Vertex Pharmaceuticals Key Executives



This page (NASDAQ:VRTX) was last updated on 11/23/2024 by MarketBeat.com Staff
From Our Partners